sorafenib 索拉非尼
- In the latter scenario, sorafenib should also constitute the control arm of these trials.
在近来的方案中,索拉菲尼将成为这些实验中的控制臂。 - Treatment duration was a median of 23 weeks in the sorafenib group and 19 weeks in the placebo group.
治疗时间中位数在索拉非尼组为23周,在安慰剂组为19周。 - For those patients with advanced HCC, who have had surgical resection, with the surgery impact the safety and efficacy of sorafenib?
对于已进行了手术的晚期肝癌患者,手术会影响索拉非尼的安全性和疗效吗?
您正在访问的是
中国词汇量第二的英语词典
更多精彩,登录后发现......